<html>
<head>PUBMED IDs for GluN3A</head>
<body bgcolor='#C5F0F2'><h1>GluN3A</h1><a href='https://pubmed.ncbi.nlm.nih.gov/23447623/'>Tyrosine phosphorylation regulates the endocytosis and surface expression of GluN3A-containing NMDA receptors.</a> April 23  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23852340/'>Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models.</a> November 2  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24386575/'>GluN3A: an NMDA receptor subunit with exquisite properties and functions.</a> July 23  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24523671/'>Selective increases of AMPA, NMDA, and kainate receptor subunit mRNAs in the hippocampus and orbitofrontal cortex but not in prefrontal cortex of human alcoholics.</a> February 14  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25994914/'>Quantitative Analysis of Glutamate Receptors in Glial Cells from the Cortex of GFAP/EGFP Mice Following Ischemic Injury: Focus on NMDA Receptors.</a> July 29  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25994910/'>[The prospects for children with acute lymphoblastic leukemia of being cured has increased in the Czech Republic in the 21st century to 90% - outcome of the ALL-IC BFM 2002 trial].</a> October 23  2015<br></body></html>
